{"cluster": 36, "subcluster": 42, "abstract_summ": "These molecules mitigated inflammatory cytokine cascades induced by viral infections via Nrf2 activating capacity and might have additional anti-fibrotic and anti-remodeling properties.The development of coronavirus-evoked pneumonia is associated with excessive inflammatory responses in the lung, known as \u201ccytokine storms,\u201d which results in pulmonary edema, atelectasis, and acute lung injury (ALI) or fatal acute respiratory distress syndrome (ARDS).With the exudation of inflammatory factors, cytokines increase abnormally in tissues and organs, interfering with the immune system, causing excessive immune response of the body, resulting in diffuse damage of lung cells, pulmonary fibrosis, and multiple organ damage, even death.The incorporation of infection rates, severity and lethality of SARS-CoV-2 infections as new outcomes of metformin usage in elderly populations at risk of developing severe COVID-19, together with the assessment of bronchial/serological titers of inflammatory cytokines and D-dimers, could provide a novel mechanistic basis for the consideration of metformin as a therapeutic strategy against the inflammatory and thrombotic states underlying the gerolavic traits of SARS-CoV-2 infection.In particular, antiviral treatment used for the treatment of several viral infections (eg, hepatitis C, HIV, Ebola, severe acute respiratory syndrome\u2013coronavirus) are today used with a mild or moderate effect on the lung injury.", "title_summ": "Severe Acute Lung Injury Related to COVID\u201019 Infection: A Review and the Possible Role for EscinMetformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implicationsPotential Role of Nrf2 Activators with Dual Antiviral and Anti-Inflammatory Properties in the Management of Viral PneumoniaSARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vapingEicosanoids: the Overlooked Storm in COVID-19?The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe PneumoniaThe contact activation system as a potential therapeutic target in patients with COVID\u201019Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?The cytokine storm of COVID-19: a spotlight on prevention and protection.[Study on treatment of \"cytokine storm\" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway].Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities.AhR and IDO1 in pathogenesis of Covid-19 and the \"Systemic AhR Activation Syndrome\" Translational review and therapeutic perspectives.", "title_abstract_phrases": "The development of coronavirus-evoked pneumonia is associated with excessive inflammatory responses in the lung, known as \u201ccytokine storms,\u201d which results in pulmonary edema, atelectasis, and acute lung injury (ALI) or fatal acute respiratory distress syndrome (ARDS).These molecules mitigated inflammatory cytokine cascades induced by viral infections via Nrf2 activating capacity and might have additional anti-fibrotic and anti-remodeling properties.Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implicationsThe lung is a key target of the cytokine storm that can be triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the widespread clinical syndrome known as coronavirus disease 2019 (COVID-19).The incorporation of infection rates, severity and lethality of SARS-CoV-2 infections as new outcomes of metformin usage in elderly populations at risk of developing severe COVID-19, together with the assessment of bronchial/serological titers of inflammatory cytokines and D-dimers, could provide a novel mechanistic basis for the consideration of metformin as a therapeutic strategy against the inflammatory and thrombotic states underlying the gerolavic traits of SARS-CoV-2 infection.In particular, antiviral treatment used for the treatment of several viral infections (eg, hepatitis C, HIV, Ebola, severe acute respiratory syndrome\u2013coronavirus) are today used with a mild or moderate effect on the lung injury."}